D

Dx & Vx Co Ltd
KOSDAQ:180400

Watchlist Manager
Dx & Vx Co Ltd
KOSDAQ:180400
Watchlist
Price: 7 740 KRW -4.33% Market Closed
Market Cap: ₩154.5B

Net Margin

-187%
Current
Declining
by 103.1%
vs 3-y average of -84%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-187%
=
Net Income
₩-50.9B
/
Revenue
₩27.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-187%
=
Net Income
₩-50.9B
/
Revenue
₩27.2B

Peer Comparison

Country Company Market Cap Net
Margin
KR
Dx & Vx Co Ltd
KOSDAQ:180400
154.5B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
388.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.3B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.4B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 95% of companies in Korea
Percentile
5th
Based on 2 632 companies
5th percentile
-187%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

Dx & Vx Co Ltd
Glance View

Market Cap
154.5B KRW
Industry
Biotechnology

Dx & Vx Co., Ltd. engages in the development of molecular diagnostic products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-12-15. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.

Intrinsic Value
7 519.12 KRW
Overvaluation 3%
Intrinsic Value
Price
D
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-187%
=
Net Income
₩-50.9B
/
Revenue
₩27.2B
What is Dx & Vx Co Ltd's current Net Margin?

The current Net Margin for Dx & Vx Co Ltd is -187%, which is below its 3-year median of -84%.

How has Net Margin changed over time?

Over the last 3 years, Dx & Vx Co Ltd’s Net Margin has decreased from -18.5% to -187%. During this period, it reached a low of -187% on Oct 30, 2025 and a high of -2.4% on Dec 31, 2022.

Back to Top